Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...

In the Lucentis Phase III clinical trials, the most common ocular side effects included conjunctival hemorrhage, eye pain, vitreous floaters, and increased intraocular pressure. The most common ...

In the Lucentis Phase III clinical trials, the most common ocular side effects included conjunctival hemorrhage, eye pain, vitreous floaters, and increased intraocular pressure. The most common ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Cataracts cloud the lenses of the eye, leading to worsening vision loss. Surgery is the typical treatment. Learn how to ...

Ayres shares insights on using a trocar-free, 27-gauge vitrector to improve surgeon comfort and patient safety in anterior ...

I read an article a few years back that said if you had vertigo, you more than likely would also have restless legs syndrome ...

The predominant story of the 2025 Eastern Conference finals has been how badly the New York Knicks have performed with their starting lineup in the game. The five-man group of Jalen Brunson, Josh ...

Nearly a year earlier, in December 2023, Middle East Eye received numerous testimonies from Palestinians that Israeli forces strapped explosives on civilians before forcing them into areas ...